nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyltestosterone—CYP2B6—Thiotepa—urinary bladder cancer	0.219	0.329	CbGbCtD
Methyltestosterone—SLCO1A2—Methotrexate—urinary bladder cancer	0.0745	0.112	CbGbCtD
Methyltestosterone—ALB—Fluorouracil—urinary bladder cancer	0.0698	0.105	CbGbCtD
Methyltestosterone—CYP3A4—Thiotepa—urinary bladder cancer	0.0673	0.101	CbGbCtD
Methyltestosterone—SLC22A8—Methotrexate—urinary bladder cancer	0.0648	0.0974	CbGbCtD
Methyltestosterone—CYP2B6—Cisplatin—urinary bladder cancer	0.0605	0.0908	CbGbCtD
Methyltestosterone—CYP2B6—Doxorubicin—urinary bladder cancer	0.0405	0.0609	CbGbCtD
Methyltestosterone—ALB—Methotrexate—urinary bladder cancer	0.0385	0.0578	CbGbCtD
Methyltestosterone—AR—scrotum—urinary bladder cancer	0.0305	0.273	CbGeAlD
Methyltestosterone—CYP3A4—Etoposide—urinary bladder cancer	0.0182	0.0274	CbGbCtD
Methyltestosterone—AR—penis—urinary bladder cancer	0.0138	0.123	CbGeAlD
Methyltestosterone—CYP3A4—Doxorubicin—urinary bladder cancer	0.0124	0.0187	CbGbCtD
Methyltestosterone—SLC22A8—urine—urinary bladder cancer	0.0101	0.0907	CbGeAlD
Methyltestosterone—Oligospermia—Gemcitabine—urinary bladder cancer	0.0089	0.0779	CcSEcCtD
Methyltestosterone—Azoospermia—Thiotepa—urinary bladder cancer	0.00823	0.0721	CcSEcCtD
Methyltestosterone—Azoospermia—Gemcitabine—urinary bladder cancer	0.00693	0.0606	CcSEcCtD
Methyltestosterone—Azoospermia—Cisplatin—urinary bladder cancer	0.00646	0.0565	CcSEcCtD
Methyltestosterone—CYP3A4—urine—urinary bladder cancer	0.00501	0.0449	CbGeAlD
Methyltestosterone—SHBG—prostate gland—urinary bladder cancer	0.00458	0.041	CbGeAlD
Methyltestosterone—Oligospermia—Methotrexate—urinary bladder cancer	0.00455	0.0399	CcSEcCtD
Methyltestosterone—Oligospermia—Epirubicin—urinary bladder cancer	0.00426	0.0373	CcSEcCtD
Methyltestosterone—Oligospermia—Doxorubicin—urinary bladder cancer	0.00394	0.0345	CcSEcCtD
Methyltestosterone—CYP19A1—prostate gland—urinary bladder cancer	0.00371	0.0333	CbGeAlD
Methyltestosterone—SLC22A8—prostate gland—urinary bladder cancer	0.00363	0.0325	CbGeAlD
Methyltestosterone—Azoospermia—Methotrexate—urinary bladder cancer	0.00354	0.031	CcSEcCtD
Methyltestosterone—Azoospermia—Epirubicin—urinary bladder cancer	0.00332	0.029	CcSEcCtD
Methyltestosterone—AR—prostate gland—urinary bladder cancer	0.00329	0.0295	CbGeAlD
Methyltestosterone—Azoospermia—Doxorubicin—urinary bladder cancer	0.00307	0.0268	CcSEcCtD
Methyltestosterone—Venous thromboembolism—Epirubicin—urinary bladder cancer	0.00304	0.0266	CcSEcCtD
Methyltestosterone—Venous thromboembolism—Doxorubicin—urinary bladder cancer	0.00281	0.0246	CcSEcCtD
Methyltestosterone—AR—seminal vesicle—urinary bladder cancer	0.00278	0.0249	CbGeAlD
Methyltestosterone—SLCO1A2—renal system—urinary bladder cancer	0.00259	0.0232	CbGeAlD
Methyltestosterone—Amenorrhoea—Thiotepa—urinary bladder cancer	0.00252	0.0221	CcSEcCtD
Methyltestosterone—SHBG—female reproductive system—urinary bladder cancer	0.0025	0.0224	CbGeAlD
Methyltestosterone—SLC22A8—renal system—urinary bladder cancer	0.00247	0.0222	CbGeAlD
Methyltestosterone—AR—epithelium—urinary bladder cancer	0.00241	0.0216	CbGeAlD
Methyltestosterone—AR—smooth muscle tissue—urinary bladder cancer	0.00233	0.0209	CbGeAlD
Methyltestosterone—SHBG—vagina—urinary bladder cancer	0.00226	0.0203	CbGeAlD
Methyltestosterone—AR—renal system—urinary bladder cancer	0.00224	0.0201	CbGeAlD
Methyltestosterone—AR—urethra—urinary bladder cancer	0.0022	0.0197	CbGeAlD
Methyltestosterone—CYP19A1—female reproductive system—urinary bladder cancer	0.00203	0.0182	CbGeAlD
Methyltestosterone—Alopecia—Mitomycin—urinary bladder cancer	0.00196	0.0171	CcSEcCtD
Methyltestosterone—Trilostane—ESR2—urinary bladder cancer	0.00184	0.173	CrCbGaD
Methyltestosterone—AR—female reproductive system—urinary bladder cancer	0.00179	0.0161	CbGeAlD
Methyltestosterone—Embolism venous—Epirubicin—urinary bladder cancer	0.00177	0.0155	CcSEcCtD
Methyltestosterone—Embolism venous—Doxorubicin—urinary bladder cancer	0.00164	0.0143	CcSEcCtD
Methyltestosterone—CYP2B6—renal system—urinary bladder cancer	0.00162	0.0146	CbGeAlD
Methyltestosterone—AR—vagina—urinary bladder cancer	0.00162	0.0145	CbGeAlD
Methyltestosterone—Headache—Valrubicin—urinary bladder cancer	0.00143	0.0125	CcSEcCtD
Methyltestosterone—Anaphylactoid reaction—Gemcitabine—urinary bladder cancer	0.0014	0.0122	CcSEcCtD
Methyltestosterone—Nausea—Valrubicin—urinary bladder cancer	0.00136	0.0119	CcSEcCtD
Methyltestosterone—Anaphylactoid reaction—Cisplatin—urinary bladder cancer	0.0013	0.0114	CcSEcCtD
Methyltestosterone—CYP2B6—female reproductive system—urinary bladder cancer	0.0013	0.0117	CbGeAlD
Methyltestosterone—CYP3A4—renal system—urinary bladder cancer	0.00123	0.011	CbGeAlD
Methyltestosterone—ALB—lymph node—urinary bladder cancer	0.00121	0.0108	CbGeAlD
Methyltestosterone—Anaphylactoid reaction—Etoposide—urinary bladder cancer	0.00119	0.0105	CcSEcCtD
Methyltestosterone—CYP19A1—lymph node—urinary bladder cancer	0.00119	0.0106	CbGeAlD
Methyltestosterone—CYP2B6—vagina—urinary bladder cancer	0.00118	0.0105	CbGeAlD
Methyltestosterone—Allylestrenol—ESR1—urinary bladder cancer	0.00116	0.109	CrCbGaD
Methyltestosterone—Mestranol—ESR1—urinary bladder cancer	0.00113	0.106	CrCbGaD
Methyltestosterone—Trilostane—ESR1—urinary bladder cancer	0.00113	0.106	CrCbGaD
Methyltestosterone—Haemoglobin—Thiotepa—urinary bladder cancer	0.00112	0.0098	CcSEcCtD
Methyltestosterone—Haemorrhage—Thiotepa—urinary bladder cancer	0.00111	0.00975	CcSEcCtD
Methyltestosterone—AR—lymph node—urinary bladder cancer	0.00105	0.00941	CbGeAlD
Methyltestosterone—Jaundice cholestatic—Epirubicin—urinary bladder cancer	0.00102	0.00889	CcSEcCtD
Methyltestosterone—Amenorrhoea—Epirubicin—urinary bladder cancer	0.00102	0.00889	CcSEcCtD
Methyltestosterone—Angiopathy—Thiotepa—urinary bladder cancer	0.00101	0.00884	CcSEcCtD
Methyltestosterone—Headache—Mitomycin—urinary bladder cancer	0.000986	0.00863	CcSEcCtD
Methyltestosterone—Alopecia—Thiotepa—urinary bladder cancer	0.000984	0.00861	CcSEcCtD
Methyltestosterone—CYP3A4—female reproductive system—urinary bladder cancer	0.000982	0.00881	CbGeAlD
Methyltestosterone—Haemoglobin—Gemcitabine—urinary bladder cancer	0.000942	0.00824	CcSEcCtD
Methyltestosterone—Jaundice cholestatic—Doxorubicin—urinary bladder cancer	0.00094	0.00823	CcSEcCtD
Methyltestosterone—Amenorrhoea—Doxorubicin—urinary bladder cancer	0.00094	0.00823	CcSEcCtD
Methyltestosterone—Haemorrhage—Gemcitabine—urinary bladder cancer	0.000937	0.0082	CcSEcCtD
Methyltestosterone—Nausea—Mitomycin—urinary bladder cancer	0.000934	0.00818	CcSEcCtD
Methyltestosterone—Haemoglobin—Fluorouracil—urinary bladder cancer	0.000926	0.0081	CcSEcCtD
Methyltestosterone—Haemorrhage—Fluorouracil—urinary bladder cancer	0.000921	0.00806	CcSEcCtD
Methyltestosterone—Etonogestrel—ESR1—urinary bladder cancer	0.000907	0.0851	CrCbGaD
Methyltestosterone—Ethinyl Estradiol—ESR2—urinary bladder cancer	0.000878	0.0824	CrCbGaD
Methyltestosterone—Gynaecomastia—Methotrexate—urinary bladder cancer	0.000854	0.00747	CcSEcCtD
Methyltestosterone—Angiopathy—Gemcitabine—urinary bladder cancer	0.00085	0.00744	CcSEcCtD
Methyltestosterone—Alopecia—Gemcitabine—urinary bladder cancer	0.000828	0.00725	CcSEcCtD
Methyltestosterone—Anxiety—Thiotepa—urinary bladder cancer	0.000822	0.0072	CcSEcCtD
Methyltestosterone—Alopecia—Fluorouracil—urinary bladder cancer	0.000814	0.00712	CcSEcCtD
Methyltestosterone—Alopecia—Cisplatin—urinary bladder cancer	0.000772	0.00675	CcSEcCtD
Methyltestosterone—Angiopathy—Etoposide—urinary bladder cancer	0.000726	0.00635	CcSEcCtD
Methyltestosterone—Anaphylactoid reaction—Methotrexate—urinary bladder cancer	0.000716	0.00626	CcSEcCtD
Methyltestosterone—Paraesthesia—Thiotepa—urinary bladder cancer	0.00071	0.00622	CcSEcCtD
Methyltestosterone—Alopecia—Etoposide—urinary bladder cancer	0.000707	0.00619	CcSEcCtD
Methyltestosterone—Anaphylactoid reaction—Epirubicin—urinary bladder cancer	0.00067	0.00586	CcSEcCtD
Methyltestosterone—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.000666	0.00583	CcSEcCtD
Methyltestosterone—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.000654	0.00573	CcSEcCtD
Methyltestosterone—Anxiety—Cisplatin—urinary bladder cancer	0.000645	0.00564	CcSEcCtD
Methyltestosterone—Levonorgestrel—ESR1—urinary bladder cancer	0.000642	0.0602	CrCbGaD
Methyltestosterone—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.00062	0.00543	CcSEcCtD
Methyltestosterone—Anaphylactoid reaction—Doxorubicin—urinary bladder cancer	0.00062	0.00542	CcSEcCtD
Methyltestosterone—Fluoxymesterone—ESR1—urinary bladder cancer	0.000611	0.0574	CrCbGaD
Methyltestosterone—Paraesthesia—Gemcitabine—urinary bladder cancer	0.000598	0.00523	CcSEcCtD
Methyltestosterone—Paraesthesia—Fluorouracil—urinary bladder cancer	0.000588	0.00514	CcSEcCtD
Methyltestosterone—Danazol—ESR1—urinary bladder cancer	0.000584	0.0548	CrCbGaD
Methyltestosterone—Anaphylactic shock—Etoposide—urinary bladder cancer	0.000568	0.00497	CcSEcCtD
Methyltestosterone—Paraesthesia—Cisplatin—urinary bladder cancer	0.000557	0.00488	CcSEcCtD
Methyltestosterone—Ethinyl Estradiol—ESR1—urinary bladder cancer	0.000541	0.0507	CrCbGaD
Methyltestosterone—Medroxyprogesterone Acetate—ESR1—urinary bladder cancer	0.000525	0.0492	CrCbGaD
Methyltestosterone—Paraesthesia—Etoposide—urinary bladder cancer	0.00051	0.00447	CcSEcCtD
Methyltestosterone—Headache—Thiotepa—urinary bladder cancer	0.000496	0.00434	CcSEcCtD
Methyltestosterone—Haemoglobin—Methotrexate—urinary bladder cancer	0.000482	0.00422	CcSEcCtD
Methyltestosterone—Haemorrhage—Methotrexate—urinary bladder cancer	0.000479	0.00419	CcSEcCtD
Methyltestosterone—Nausea—Thiotepa—urinary bladder cancer	0.00047	0.00411	CcSEcCtD
Methyltestosterone—Haemoglobin—Epirubicin—urinary bladder cancer	0.000451	0.00394	CcSEcCtD
Methyltestosterone—Haemorrhage—Epirubicin—urinary bladder cancer	0.000448	0.00392	CcSEcCtD
Methyltestosterone—Angiopathy—Methotrexate—urinary bladder cancer	0.000435	0.0038	CcSEcCtD
Methyltestosterone—Alopecia—Methotrexate—urinary bladder cancer	0.000423	0.00371	CcSEcCtD
Methyltestosterone—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000417	0.00365	CcSEcCtD
Methyltestosterone—Headache—Gemcitabine—urinary bladder cancer	0.000417	0.00365	CcSEcCtD
Methyltestosterone—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000415	0.00363	CcSEcCtD
Methyltestosterone—Headache—Fluorouracil—urinary bladder cancer	0.00041	0.00359	CcSEcCtD
Methyltestosterone—Angiopathy—Epirubicin—urinary bladder cancer	0.000407	0.00356	CcSEcCtD
Methyltestosterone—Alopecia—Epirubicin—urinary bladder cancer	0.000396	0.00347	CcSEcCtD
Methyltestosterone—Nausea—Gemcitabine—urinary bladder cancer	0.000395	0.00346	CcSEcCtD
Methyltestosterone—Drospirenone—PTGS2—urinary bladder cancer	0.000393	0.0369	CrCbGaD
Methyltestosterone—Nausea—Fluorouracil—urinary bladder cancer	0.000389	0.0034	CcSEcCtD
Methyltestosterone—Angiopathy—Doxorubicin—urinary bladder cancer	0.000376	0.00329	CcSEcCtD
Methyltestosterone—Nausea—Cisplatin—urinary bladder cancer	0.000368	0.00323	CcSEcCtD
Methyltestosterone—Alopecia—Doxorubicin—urinary bladder cancer	0.000367	0.00321	CcSEcCtD
Methyltestosterone—Headache—Etoposide—urinary bladder cancer	0.000356	0.00312	CcSEcCtD
Methyltestosterone—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.00034	0.00298	CcSEcCtD
Methyltestosterone—Nausea—Etoposide—urinary bladder cancer	0.000338	0.00295	CcSEcCtD
Methyltestosterone—Anxiety—Epirubicin—urinary bladder cancer	0.000331	0.0029	CcSEcCtD
Methyltestosterone—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000319	0.00279	CcSEcCtD
Methyltestosterone—Anxiety—Doxorubicin—urinary bladder cancer	0.000306	0.00268	CcSEcCtD
Methyltestosterone—Paraesthesia—Methotrexate—urinary bladder cancer	0.000306	0.00268	CcSEcCtD
Methyltestosterone—Progesterone—ESR1—urinary bladder cancer	0.000303	0.0284	CrCbGaD
Methyltestosterone—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000295	0.00258	CcSEcCtD
Methyltestosterone—Paraesthesia—Epirubicin—urinary bladder cancer	0.000286	0.0025	CcSEcCtD
Methyltestosterone—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000265	0.00232	CcSEcCtD
Methyltestosterone—Headache—Methotrexate—urinary bladder cancer	0.000213	0.00187	CcSEcCtD
Methyltestosterone—Nausea—Methotrexate—urinary bladder cancer	0.000202	0.00177	CcSEcCtD
Methyltestosterone—Headache—Epirubicin—urinary bladder cancer	0.0002	0.00175	CcSEcCtD
Methyltestosterone—Nausea—Epirubicin—urinary bladder cancer	0.000189	0.00166	CcSEcCtD
Methyltestosterone—Headache—Doxorubicin—urinary bladder cancer	0.000185	0.00162	CcSEcCtD
Methyltestosterone—Nausea—Doxorubicin—urinary bladder cancer	0.000175	0.00153	CcSEcCtD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	0.00017	0.00174	CbGpPWpGaD
Methyltestosterone—ALB—Selenium Micronutrient Network—MTHFR—urinary bladder cancer	0.000166	0.00169	CbGpPWpGaD
Methyltestosterone—AR—Androgen receptor signaling pathway—EGFR—urinary bladder cancer	0.00016	0.00163	CbGpPWpGaD
Methyltestosterone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000155	0.00158	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—RB1—urinary bladder cancer	0.000154	0.00158	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—CDH1—urinary bladder cancer	0.000154	0.00157	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—GSTZ1—urinary bladder cancer	0.00015	0.00153	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	0.000149	0.00152	CbGpPWpGaD
Methyltestosterone—ALB—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000148	0.00151	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	0.000147	0.0015	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—GSTO2—urinary bladder cancer	0.000142	0.00145	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—NAT1—urinary bladder cancer	0.000142	0.00145	CbGpPWpGaD
Methyltestosterone—CYP2B6—Biological oxidations—GSTP1—urinary bladder cancer	0.000142	0.00145	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.00014	0.00143	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.00014	0.00142	CbGpPWpGaD
Methyltestosterone—AR—Generic Transcription Pathway—ESR2—urinary bladder cancer	0.000139	0.00142	CbGpPWpGaD
Methyltestosterone—AR—SIDS Susceptibility Pathways—CXCL8—urinary bladder cancer	0.000139	0.00142	CbGpPWpGaD
Methyltestosterone—ALB—Platelet degranulation—IGF1—urinary bladder cancer	0.000138	0.0014	CbGpPWpGaD
Methyltestosterone—SLC22A8—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000136	0.00139	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—GSTZ1—urinary bladder cancer	0.000135	0.00138	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—CCND1—urinary bladder cancer	0.000133	0.00136	CbGpPWpGaD
Methyltestosterone—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—urinary bladder cancer	0.000131	0.00134	CbGpPWpGaD
Methyltestosterone—CYP2B6—Biological oxidations—GSTM1—urinary bladder cancer	0.00013	0.00133	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—UGT2B7—urinary bladder cancer	0.00013	0.00132	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—PTEN—urinary bladder cancer	0.000129	0.00131	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000128	0.00131	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—GSTO2—urinary bladder cancer	0.000128	0.00131	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—NAT1—urinary bladder cancer	0.000128	0.00131	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000128	0.00131	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000126	0.00129	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	0.000125	0.00128	CbGpPWpGaD
Methyltestosterone—ALB—Folate Metabolism—IL2—urinary bladder cancer	0.000123	0.00126	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—EP300—urinary bladder cancer	0.000123	0.00125	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	0.000122	0.00125	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000121	0.00123	CbGpPWpGaD
Methyltestosterone—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	0.00012	0.00122	CbGpPWpGaD
Methyltestosterone—AR—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	0.00012	0.00122	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000118	0.00121	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—UGT2B7—urinary bladder cancer	0.000117	0.0012	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—CYP4B1—urinary bladder cancer	0.000117	0.00119	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—CCND1—urinary bladder cancer	0.000115	0.00117	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—PTEN—urinary bladder cancer	0.000111	0.00113	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	0.00011	0.00113	CbGpPWpGaD
Methyltestosterone—ALB—Vitamin B12 Metabolism—TNF—urinary bladder cancer	0.00011	0.00113	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—SLC19A1—urinary bladder cancer	0.00011	0.00113	CbGpPWpGaD
Methyltestosterone—AR—Generic Transcription Pathway—NCOR1—urinary bladder cancer	0.000108	0.0011	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—PRSS3—urinary bladder cancer	0.000107	0.0011	CbGpPWpGaD
Methyltestosterone—ALB—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000107	0.00109	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—MYC—urinary bladder cancer	0.000107	0.00109	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	0.000107	0.00109	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	0.000107	0.00109	CbGpPWpGaD
Methyltestosterone—ALB—Selenium Micronutrient Network—PTGS2—urinary bladder cancer	0.000106	0.00108	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—CYP4B1—urinary bladder cancer	0.000106	0.00108	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—EP300—urinary bladder cancer	0.000106	0.00108	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—EGFR—urinary bladder cancer	0.000105	0.00107	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	0.000102	0.00104	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—SLC19A1—urinary bladder cancer	9.97e-05	0.00102	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	9.88e-05	0.00101	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—KRAS—urinary bladder cancer	9.88e-05	0.00101	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—PRSS3—urinary bladder cancer	9.71e-05	0.000992	CbGpPWpGaD
Methyltestosterone—AR—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	9.7e-05	0.00099	CbGpPWpGaD
Methyltestosterone—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	9.58e-05	0.000978	CbGpPWpGaD
Methyltestosterone—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	9.29e-05	0.000949	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—MYC—urinary bladder cancer	9.2e-05	0.000939	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—EGFR—urinary bladder cancer	9e-05	0.000918	CbGpPWpGaD
Methyltestosterone—ALB—Folate Metabolism—TNF—urinary bladder cancer	8.98e-05	0.000917	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	8.86e-05	0.000904	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—TP53—urinary bladder cancer	8.78e-05	0.000896	CbGpPWpGaD
Methyltestosterone—ALB—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	8.72e-05	0.00089	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—GSTZ1—urinary bladder cancer	8.68e-05	0.000887	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	8.66e-05	0.000884	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	8.62e-05	0.00088	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—TYMP—urinary bladder cancer	8.59e-05	0.000877	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—KRAS—urinary bladder cancer	8.5e-05	0.000868	CbGpPWpGaD
Methyltestosterone—AR—Generic Transcription Pathway—ESR1—urinary bladder cancer	8.46e-05	0.000864	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	8.25e-05	0.000843	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	8.25e-05	0.000842	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—GSTO2—urinary bladder cancer	8.23e-05	0.00084	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—NAT1—urinary bladder cancer	8.23e-05	0.00084	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	8.18e-05	0.000835	CbGpPWpGaD
Methyltestosterone—ALB—Folate Metabolism—TP53—urinary bladder cancer	7.92e-05	0.000808	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	7.79e-05	0.000795	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—NAT2—urinary bladder cancer	7.77e-05	0.000793	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—TYMP—urinary bladder cancer	7.77e-05	0.000793	CbGpPWpGaD
Methyltestosterone—AR—Generic Transcription Pathway—PPARG—urinary bladder cancer	7.72e-05	0.000788	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—SMC1A—urinary bladder cancer	7.7e-05	0.000787	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—TP53—urinary bladder cancer	7.55e-05	0.000771	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—UGT2B7—urinary bladder cancer	7.53e-05	0.000769	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	7.46e-05	0.000761	CbGpPWpGaD
Methyltestosterone—AR—Generic Transcription Pathway—CREBBP—urinary bladder cancer	7.41e-05	0.000757	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—GSTZ1—urinary bladder cancer	7.31e-05	0.000746	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	7.27e-05	0.000743	CbGpPWpGaD
Methyltestosterone—ALB—Selenium Micronutrient Network—TNF—urinary bladder cancer	7.13e-05	0.000728	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—NAT2—urinary bladder cancer	7.02e-05	0.000717	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—GSTO2—urinary bladder cancer	6.93e-05	0.000707	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—NAT1—urinary bladder cancer	6.93e-05	0.000707	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	6.82e-05	0.000696	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—CYP4B1—urinary bladder cancer	6.78e-05	0.000692	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—ESR2—urinary bladder cancer	6.72e-05	0.000686	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—RRM2—urinary bladder cancer	6.71e-05	0.000685	CbGpPWpGaD
Methyltestosterone—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	6.44e-05	0.000658	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—SLC19A1—urinary bladder cancer	6.4e-05	0.000654	CbGpPWpGaD
Methyltestosterone—SLC22A8—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	6.35e-05	0.000649	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	6.35e-05	0.000649	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—UGT2B7—urinary bladder cancer	6.34e-05	0.000647	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—PRSS3—urinary bladder cancer	6.24e-05	0.000637	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—HPGDS—urinary bladder cancer	6.21e-05	0.000634	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—ENO2—urinary bladder cancer	6.21e-05	0.000634	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	6.18e-05	0.000631	CbGpPWpGaD
Methyltestosterone—ALB—Platelet activation, signaling and aggregation—IGF1—urinary bladder cancer	6.1e-05	0.000623	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—RRM2—urinary bladder cancer	6.06e-05	0.000619	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—GSTT1—urinary bladder cancer	6.03e-05	0.000615	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	5.93e-05	0.000606	CbGpPWpGaD
Methyltestosterone—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	5.92e-05	0.000604	CbGpPWpGaD
Methyltestosterone—ALB—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	5.89e-05	0.000601	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	5.84e-05	0.000596	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—CYP4B1—urinary bladder cancer	5.71e-05	0.000583	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	5.64e-05	0.000576	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—HPGDS—urinary bladder cancer	5.62e-05	0.000573	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—ENO2—urinary bladder cancer	5.62e-05	0.000573	CbGpPWpGaD
Methyltestosterone—ALB—Platelet activation, signaling and aggregation—RHOA—urinary bladder cancer	5.59e-05	0.000571	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	5.58e-05	0.00057	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—GSTT1—urinary bladder cancer	5.45e-05	0.000556	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—IFNA2—urinary bladder cancer	5.44e-05	0.000555	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—SLC19A1—urinary bladder cancer	5.39e-05	0.00055	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	5.36e-05	0.000547	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—PRSS3—urinary bladder cancer	5.25e-05	0.000536	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—NCOR1—urinary bladder cancer	5.18e-05	0.000529	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—NQO1—urinary bladder cancer	5.01e-05	0.000511	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—TYMP—urinary bladder cancer	4.99e-05	0.000509	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—ERCC2—urinary bladder cancer	4.87e-05	0.000498	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	4.86e-05	0.000496	CbGpPWpGaD
Methyltestosterone—ALB—Platelet activation, signaling and aggregation—IL2—urinary bladder cancer	4.69e-05	0.000479	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—NQO1—urinary bladder cancer	4.53e-05	0.000462	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—NAT2—urinary bladder cancer	4.51e-05	0.00046	CbGpPWpGaD
Methyltestosterone—AR—Generic Transcription Pathway—MYC—urinary bladder cancer	4.4e-05	0.000449	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	4.39e-05	0.000448	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	4.24e-05	0.000433	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	4.21e-05	0.00043	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—TYMP—urinary bladder cancer	4.2e-05	0.000429	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—GSTP1—urinary bladder cancer	4.18e-05	0.000426	CbGpPWpGaD
Methyltestosterone—ALB—Platelet activation, signaling and aggregation—SRC—urinary bladder cancer	4.09e-05	0.000418	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—ESR1—urinary bladder cancer	4.07e-05	0.000416	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	4.04e-05	0.000413	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	4.03e-05	0.000412	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	3.95e-05	0.000403	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—RRM2—urinary bladder cancer	3.89e-05	0.000397	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—TYMS—urinary bladder cancer	3.88e-05	0.000396	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—PLAU—urinary bladder cancer	3.86e-05	0.000394	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—NCOR1—urinary bladder cancer	3.84e-05	0.000392	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—GSTM1—urinary bladder cancer	3.84e-05	0.000392	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	3.83e-05	0.000391	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—NAT2—urinary bladder cancer	3.8e-05	0.000388	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—GSTP1—urinary bladder cancer	3.77e-05	0.000385	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	3.74e-05	0.000382	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—NAT1—urinary bladder cancer	3.74e-05	0.000382	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—PPARG—urinary bladder cancer	3.72e-05	0.000379	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—GPX1—urinary bladder cancer	3.68e-05	0.000375	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	3.65e-05	0.000373	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—ERCC2—urinary bladder cancer	3.61e-05	0.000368	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—HPGDS—urinary bladder cancer	3.61e-05	0.000368	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—ENO2—urinary bladder cancer	3.61e-05	0.000368	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—CREBBP—urinary bladder cancer	3.57e-05	0.000364	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—TYMS—urinary bladder cancer	3.51e-05	0.000358	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—GSTT1—urinary bladder cancer	3.5e-05	0.000357	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—NCOR1—urinary bladder cancer	3.47e-05	0.000354	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—GSTM1—urinary bladder cancer	3.47e-05	0.000354	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	3.42e-05	0.000349	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—MTHFR—urinary bladder cancer	3.39e-05	0.000346	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—GPX1—urinary bladder cancer	3.32e-05	0.000339	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—RRM2—urinary bladder cancer	3.28e-05	0.000335	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—ERCC2—urinary bladder cancer	3.26e-05	0.000333	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—CREBBP—urinary bladder cancer	3.18e-05	0.000325	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—IGF1—urinary bladder cancer	3.14e-05	0.000321	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	3.08e-05	0.000314	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—MTHFR—urinary bladder cancer	3.07e-05	0.000313	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—ENO2—urinary bladder cancer	3.04e-05	0.00031	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—HPGDS—urinary bladder cancer	3.04e-05	0.00031	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.02e-05	0.000308	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—GSTT1—urinary bladder cancer	2.94e-05	0.000301	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	2.91e-05	0.000297	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—NQO1—urinary bladder cancer	2.91e-05	0.000297	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.9e-05	0.000296	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—RHOA—urinary bladder cancer	2.88e-05	0.000294	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	2.84e-05	0.000289	CbGpPWpGaD
Methyltestosterone—ALB—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.76e-05	0.000281	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—PPARG—urinary bladder cancer	2.75e-05	0.000281	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—CREBBP—urinary bladder cancer	2.64e-05	0.00027	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—PPARG—urinary bladder cancer	2.49e-05	0.000254	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—NQO1—urinary bladder cancer	2.45e-05	0.00025	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—GSTP1—urinary bladder cancer	2.42e-05	0.000247	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—IL2—urinary bladder cancer	2.42e-05	0.000247	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—CREBBP—urinary bladder cancer	2.39e-05	0.000244	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.37e-05	0.000242	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—TYMP—urinary bladder cancer	2.27e-05	0.000231	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—TYMS—urinary bladder cancer	2.25e-05	0.00023	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—GSTM1—urinary bladder cancer	2.23e-05	0.000227	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—NCOR1—urinary bladder cancer	2.23e-05	0.000227	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—EP300—urinary bladder cancer	2.17e-05	0.000221	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—PTGS2—urinary bladder cancer	2.16e-05	0.000221	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—GPX1—urinary bladder cancer	2.13e-05	0.000218	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—MYC—urinary bladder cancer	2.12e-05	0.000216	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—SRC—urinary bladder cancer	2.11e-05	0.000215	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—ERCC2—urinary bladder cancer	2.09e-05	0.000214	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.07e-05	0.000211	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—NAT2—urinary bladder cancer	2.05e-05	0.000209	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—GSTP1—urinary bladder cancer	2.04e-05	0.000208	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.97e-05	0.000202	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—MTHFR—urinary bladder cancer	1.97e-05	0.000201	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—PTGS2—urinary bladder cancer	1.96e-05	0.0002	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—TYMS—urinary bladder cancer	1.9e-05	0.000194	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—PTEN—urinary bladder cancer	1.89e-05	0.000193	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—NCOR1—urinary bladder cancer	1.88e-05	0.000191	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—GSTM1—urinary bladder cancer	1.88e-05	0.000191	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—EP300—urinary bladder cancer	1.8e-05	0.000184	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—GPX1—urinary bladder cancer	1.8e-05	0.000183	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—RRM2—urinary bladder cancer	1.77e-05	0.000181	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—ERCC2—urinary bladder cancer	1.76e-05	0.00018	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—KRAS—urinary bladder cancer	1.75e-05	0.000178	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—PTEN—urinary bladder cancer	1.71e-05	0.000174	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—MTHFR—urinary bladder cancer	1.66e-05	0.000169	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	1.64e-05	0.000167	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—ENO2—urinary bladder cancer	1.64e-05	0.000167	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—EP300—urinary bladder cancer	1.63e-05	0.000166	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—PPARG—urinary bladder cancer	1.6e-05	0.000163	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	1.59e-05	0.000162	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—TP53—urinary bladder cancer	1.55e-05	0.000158	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—CREBBP—urinary bladder cancer	1.53e-05	0.000157	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—HRAS—urinary bladder cancer	1.48e-05	0.000152	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—PPARG—urinary bladder cancer	1.34e-05	0.000137	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.32e-05	0.000135	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—CREBBP—urinary bladder cancer	1.29e-05	0.000132	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—PTGS2—urinary bladder cancer	1.26e-05	0.000128	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.1e-05	0.000112	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—PTEN—urinary bladder cancer	1.1e-05	0.000112	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—PTGS2—urinary bladder cancer	1.06e-05	0.000108	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—EP300—urinary bladder cancer	1.04e-05	0.000107	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—TYMS—urinary bladder cancer	1.02e-05	0.000105	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.01e-05	0.000103	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.01e-05	0.000103	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—GPX1—urinary bladder cancer	9.69e-06	9.9e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	9.52e-06	9.72e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—PTEN—urinary bladder cancer	9.22e-06	9.41e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	8.95e-06	9.13e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—EP300—urinary bladder cancer	8.79e-06	8.98e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—PPARG—urinary bladder cancer	7.25e-06	7.41e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	6.97e-06	7.11e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	5.71e-06	5.83e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—PTEN—urinary bladder cancer	4.98e-06	5.08e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—EP300—urinary bladder cancer	4.75e-06	4.85e-05	CbGpPWpGaD
